HOME - APVC

APVC is a leading medical technology venture capital firm founded by GlaxoSmithKline in 2013. We invest around the world and take a hands-on role on the boards of start-ups advancing bioelectronic medicines and their enabling technologies. We believe in the fundamental advantage of a diverse workplace and are committed to

creating a fairer

TEAM - APVC - HOME - APVC Juan-Pablo Mas. Juan-Pablo is a partner at APVC in Palo Alto, CA. He represents APVC on the Boards of Cala Health, CVRx, Exo Imaging, Neuspera Medical, Presidio Medical, Saluda Medical, and SetPoint Medical. He was previously an investor at Lightstone Ventures and Morgenthaler Ventures. He previously served as a Board observer at

Ardian

UPDATES - APVC

27 January 2021. SetPoint Medical Raises $64M in Preferred Stock Financing to Support Pivotal Trial for its Novel Bioelectronic Platform. Portfolio News. read more. News & Comments. 26 January 2021. We are proud to announce that APVC Executive-in-Residence, Rami Elghandour was recently appointed Chairman of the Board and CEO of

Arcellx.

PORTFOLIO - APVC - HOME - APVC Saluda Medical. Saluda Medical is dedicated to improving patients’ lives by providing personalized and responsive neuromodulation therapy. The company has developed Evoke®, the first and only Closed-Loop Spinal Cord Stimulation (SCS) System designed to optimize pain relief by measuring and recording each patient’s unique response to stimulation, and then making millions of real-time

PRIVACY NOTICE

Your trust is important to us. We are Action Potential Venture Capital Limited (“APVC”), a wholly owned subsidiary in the GlaxoSmithKline (“GSK”) group of companies.

COOKIE POLICY

This website and the contact information contained therein is not intended for reporting adverse events. If you have a question about a GSK product or want to report a side effect, please call the GSK Response Center at 1-888-825-5249.

HOME - APVC

APVC is a leading medical technology venture capital firm founded by GlaxoSmithKline in 2013. We invest around the world and take a hands-on role on the boards of start-ups advancing bioelectronic medicines and their enabling technologies. We believe in the fundamental advantage of a diverse workplace and are committed to

creating a fairer

TEAM - APVC - HOME - APVC Juan-Pablo Mas. Juan-Pablo is a partner at APVC in Palo Alto, CA. He represents APVC on the Boards of Cala Health, CVRx, Exo Imaging, Neuspera Medical, Presidio Medical, Saluda Medical, and SetPoint Medical. He was previously an investor at Lightstone Ventures and Morgenthaler Ventures. He previously served as a Board observer at

Ardian

UPDATES - APVC

27 January 2021. SetPoint Medical Raises $64M in Preferred Stock Financing to Support Pivotal Trial for its Novel Bioelectronic Platform. Portfolio News. read more. News & Comments. 26 January 2021. We are proud to announce that APVC Executive-in-Residence, Rami Elghandour was recently appointed Chairman of the Board and CEO of

Arcellx.

PORTFOLIO - APVC - HOME - APVC Saluda Medical. Saluda Medical is dedicated to improving patients’ lives by providing personalized and responsive neuromodulation therapy. The company has developed Evoke®, the first and only Closed-Loop Spinal Cord Stimulation (SCS) System designed to optimize pain relief by measuring and recording each patient’s unique response to stimulation, and then making millions of real-time

PRIVACY NOTICE

Your trust is important to us. We are Action Potential Venture Capital Limited (“APVC”), a wholly owned subsidiary in the GlaxoSmithKline (“GSK”) group of companies.

COOKIE POLICY

This website and the contact information contained therein is not intended for reporting adverse events. If you have a question about a GSK product or want to report a side effect, please call the GSK Response Center at 1-888-825-5249.

HOME - APVC

APVC is a leading medical technology venture capital firm founded by GlaxoSmithKline in 2013. We invest around the world and take a hands-on role on the boards of start-ups advancing bioelectronic medicines and their enabling technologies. We believe in the fundamental advantage of a diverse workplace and are committed to

creating a fairer

TEAM - APVC - HOME - APVC Juan-Pablo Mas. Juan-Pablo is a partner at APVC in Palo Alto, CA. He represents APVC on the Boards of Cala Health, CVRx, Exo Imaging, Neuspera Medical, Presidio Medical, Saluda Medical, and SetPoint Medical. He was previously an investor at Lightstone Ventures and Morgenthaler Ventures. He previously served as a Board observer at

Ardian

UPDATES - APVC

27 January 2021. SetPoint Medical Raises $64M in Preferred Stock Financing to Support Pivotal Trial for its Novel Bioelectronic Platform. Portfolio News. read more. News & Comments. 26 January 2021. We are proud to announce that APVC Executive-in-Residence, Rami Elghandour was recently appointed Chairman of the Board and CEO of

Arcellx.

PORTFOLIO - APVC

Saluda Medical. Saluda Medical is dedicated to improving patients’ lives by providing personalized and responsive neuromodulation therapy. The company has developed Evoke®, the first and only Closed-Loop Spinal Cord Stimulation (SCS) System designed to optimize pain relief by measuring and recording each patient’s unique response to stimulation, and then making millions of real-time

PRIVACY NOTICE

Your trust is important to us. We are Action Potential Venture Capital Limited (“APVC”), a wholly owned subsidiary in the GlaxoSmithKline (“GSK”) group of companies.

COOKIE POLICY

This website and the contact information contained therein is not intended for reporting adverse events. If you have a question about a GSK product or want to report a side effect, please call the GSK Response Center at 1-888-825-5249.

HOME - APVC

APVC is a leading medical technology venture capital firm founded by GlaxoSmithKline in 2013. We invest around the world and take a hands-on role on the boards of start-ups advancing bioelectronic medicines and their enabling technologies. We believe in the fundamental advantage of a diverse workplace and are committed to

creating a fairer

TEAM - APVC - HOME - APVC Juan-Pablo Mas. Juan-Pablo is a partner at APVC in Palo Alto, CA. He represents APVC on the Boards of Cala Health, CVRx, Exo Imaging, Neuspera Medical, Presidio Medical, Saluda Medical, and SetPoint Medical. He was previously an investor at Lightstone Ventures and Morgenthaler Ventures. He previously served as a Board observer at

Ardian

UPDATES - APVC

27 January 2021. SetPoint Medical Raises $64M in Preferred Stock Financing to Support Pivotal Trial for its Novel Bioelectronic Platform. Portfolio News. read more. News & Comments. 26 January 2021. We are proud to announce that APVC Executive-in-Residence, Rami Elghandour was recently appointed Chairman of the Board and CEO of

Arcellx.

PORTFOLIO - APVC - HOME - APVC Saluda Medical. Saluda Medical is dedicated to improving patients’ lives by providing personalized and responsive neuromodulation therapy. The company has developed Evoke®, the first and only Closed-Loop Spinal Cord Stimulation (SCS) System designed to optimize pain relief by measuring and recording each patient’s unique response to stimulation, and then making millions of real-time

COOKIE POLICY

This website and the contact information contained therein is not intended for reporting adverse events. If you have a question about a GSK product or want to report a side effect, please call the GSK Response Center at 1-888-825-5249.

PRIVACY NOTICE

Your trust is important to us. We are Action Potential Venture Capital Limited (“APVC”), a wholly owned subsidiary in the GlaxoSmithKline (“GSK”) group of companies.

HOME - APVC

APVC is a leading medical technology venture capital firm founded by GlaxoSmithKline in 2013. We invest around the world and take a hands-on role on the boards of start-ups advancing bioelectronic medicines and their enabling technologies. We believe in the fundamental advantage of a diverse workplace and are committed to

creating a fairer

TEAM - APVC - HOME - APVC Juan-Pablo Mas. Juan-Pablo is a partner at APVC in Palo Alto, CA. He represents APVC on the Boards of Cala Health, CVRx, Exo Imaging, Neuspera Medical, Presidio Medical, Saluda Medical, and SetPoint Medical. He was previously an investor at Lightstone Ventures and Morgenthaler Ventures. He previously served as a Board observer at

Ardian

UPDATES - APVC

27 January 2021. SetPoint Medical Raises $64M in Preferred Stock Financing to Support Pivotal Trial for its Novel Bioelectronic Platform. Portfolio News. read more. News & Comments. 26 January 2021. We are proud to announce that APVC Executive-in-Residence, Rami Elghandour was recently appointed Chairman of the Board and CEO of

Arcellx.

PORTFOLIO - APVC - HOME - APVC Saluda Medical. Saluda Medical is dedicated to improving patients’ lives by providing personalized and responsive neuromodulation therapy. The company has developed Evoke®, the first and only Closed-Loop Spinal Cord Stimulation (SCS) System designed to optimize pain relief by measuring and recording each patient’s unique response to stimulation, and then making millions of real-time

COOKIE POLICY

This website and the contact information contained therein is not intended for reporting adverse events. If you have a question about a GSK product or want to report a side effect, please call the GSK Response Center at 1-888-825-5249.

PRIVACY NOTICE

Your trust is important to us. We are Action Potential Venture Capital Limited (“APVC”), a wholly owned subsidiary in the GlaxoSmithKline (“GSK”) group of companies.

HOME - APVC

APVC is a leading medical technology venture capital firm founded by GlaxoSmithKline in 2013. We invest around the world and take a hands-on role on the boards of start-ups advancing bioelectronic medicines and their enabling technologies. We believe in the fundamental advantage of a diverse workplace and are committed to

creating a fairer

TEAM - APVC - HOME - APVC Juan-Pablo Mas. Juan-Pablo is a partner at APVC in Palo Alto, CA. He represents APVC on the Boards of Cala Health, CVRx, Exo Imaging, Neuspera Medical, Presidio Medical, Saluda Medical, and SetPoint Medical. He was previously an investor at Lightstone Ventures and Morgenthaler Ventures. He previously served as a Board observer at

Ardian

UPDATES - APVC

27 January 2021. SetPoint Medical Raises $64M in Preferred Stock Financing to Support Pivotal Trial for its Novel Bioelectronic Platform. Portfolio News. read more. News & Comments. 26 January 2021. We are proud to announce that APVC Executive-in-Residence, Rami Elghandour was recently appointed Chairman of the Board and CEO of

Arcellx.

PORTFOLIO - APVC - HOME - APVC Saluda Medical. Saluda Medical is dedicated to improving patients’ lives by providing personalized and responsive neuromodulation therapy. The company has developed Evoke®, the first and only Closed-Loop Spinal Cord Stimulation (SCS) System designed to optimize pain relief by measuring and recording each patient’s unique response to stimulation, and then making millions of real-time

COOKIE POLICY

This website and the contact information contained therein is not intended for reporting adverse events. If you have a question about a GSK product or want to report a side effect, please call the GSK Response Center at 1-888-825-5249.

PRIVACY NOTICE

Your trust is important to us. We are Action Potential Venture Capital Limited (“APVC”), a wholly owned subsidiary in the GlaxoSmithKline (“GSK”) group of companies.

HOME - APVC

APVC is a leading medical technology venture capital firm founded by GlaxoSmithKline in 2013. We invest around the world and take a hands-on role on the boards of start-ups advancing bioelectronic medicines and their enabling technologies. We believe in the fundamental advantage of a diverse workplace and are committed to

creating a fairer

TEAM - APVC - HOME - APVC Juan-Pablo Mas. Juan-Pablo is a partner at APVC in Palo Alto, CA. He represents APVC on the Boards of Cala Health, CVRx, Exo Imaging, Neuspera Medical, Presidio Medical, Saluda Medical, and SetPoint Medical. He was previously an investor at Lightstone Ventures and Morgenthaler Ventures. He previously served as a Board observer at

Ardian

UPDATES - APVC

27 January 2021. SetPoint Medical Raises $64M in Preferred Stock Financing to Support Pivotal Trial for its Novel Bioelectronic Platform. Portfolio News. read more. News & Comments. 26 January 2021. We are proud to announce that APVC Executive-in-Residence, Rami Elghandour was recently appointed Chairman of the Board and CEO of

Arcellx.

PORTFOLIO - APVC - HOME - APVC Saluda Medical. Saluda Medical is dedicated to improving patients’ lives by providing personalized and responsive neuromodulation therapy. The company has developed Evoke®, the first and only Closed-Loop Spinal Cord Stimulation (SCS) System designed to optimize pain relief by measuring and recording each patient’s unique response to stimulation, and then making millions of real-time

COOKIE POLICY

This website and the contact information contained therein is not intended for reporting adverse events. If you have a question about a GSK product or want to report a side effect, please call the GSK Response Center at 1-888-825-5249.

PRIVACY NOTICE

Your trust is important to us. We are Action Potential Venture Capital Limited (“APVC”), a wholly owned subsidiary in the GlaxoSmithKline (“GSK”) group of companies.

HOME - APVC

APVC is a leading medical technology venture capital firm founded by GlaxoSmithKline in 2013. We invest around the world and take a hands-on role on the boards of start-ups advancing bioelectronic medicines and their enabling technologies. We believe in the fundamental advantage of a diverse workplace and are committed to

creating a fairer

TEAM - APVC - HOME - APVC Juan-Pablo Mas. Juan-Pablo is a partner at APVC in Palo Alto, CA. He represents APVC on the Boards of Cala Health, CVRx, Exo Imaging, Neuspera Medical, Presidio Medical, Saluda Medical, and SetPoint Medical. He was previously an investor at Lightstone Ventures and Morgenthaler Ventures. He previously served as a Board observer at

Ardian

UPDATES - APVC

27 January 2021. SetPoint Medical Raises $64M in Preferred Stock Financing to Support Pivotal Trial for its Novel Bioelectronic Platform. Portfolio News. read more. News & Comments. 26 January 2021. We are proud to announce that APVC Executive-in-Residence, Rami Elghandour was recently appointed Chairman of the Board and CEO of

Arcellx.

PORTFOLIO - APVC - HOME - APVC Saluda Medical. Saluda Medical is dedicated to improving patients’ lives by providing personalized and responsive neuromodulation therapy. The company has developed Evoke®, the first and only Closed-Loop Spinal Cord Stimulation (SCS) System designed to optimize pain relief by measuring and recording each patient’s unique response to stimulation, and then making millions of real-time

COOKIE POLICY

This website and the contact information contained therein is not intended for reporting adverse events. If you have a question about a GSK product or want to report a side effect, please call the GSK Response Center at 1-888-825-5249.

PRIVACY NOTICE

Your trust is important to us. We are Action Potential Venture Capital Limited (“APVC”), a wholly owned subsidiary in the GlaxoSmithKline (“GSK”) group of companies.

HOME - APVC

APVC is a leading medical technology venture capital firm founded by GlaxoSmithKline in 2013. We invest around the world and take a hands-on role on the boards of start-ups advancing bioelectronic medicines and their enabling technologies. We believe in the fundamental advantage of a diverse workplace and are committed to

creating a fairer

TEAM - APVC - HOME - APVC Juan-Pablo Mas. Juan-Pablo is a partner at APVC in Palo Alto, CA. He represents APVC on the Boards of Cala Health, CVRx, Exo Imaging, Neuspera Medical, Presidio Medical, Saluda Medical, and SetPoint Medical. He was previously an investor at Lightstone Ventures and Morgenthaler Ventures. He previously served as a Board observer at

Ardian

UPDATES - APVC

27 January 2021. SetPoint Medical Raises $64M in Preferred Stock Financing to Support Pivotal Trial for its Novel Bioelectronic Platform. Portfolio News. read more. News & Comments. 26 January 2021. We are proud to announce that APVC Executive-in-Residence, Rami Elghandour was recently appointed Chairman of the Board and CEO of

Arcellx.

PORTFOLIO - APVC - HOME - APVC Saluda Medical. Saluda Medical is dedicated to improving patients’ lives by providing personalized and responsive neuromodulation therapy. The company has developed Evoke®, the first and only Closed-Loop Spinal Cord Stimulation (SCS) System designed to optimize pain relief by measuring and recording each patient’s unique response to stimulation, and then making millions of real-time

COOKIE POLICY

This website and the contact information contained therein is not intended for reporting adverse events. If you have a question about a GSK product or want to report a side effect, please call the GSK Response Center at 1-888-825-5249.

PRIVACY NOTICE

Your trust is important to us. We are Action Potential Venture Capital Limited (“APVC”), a wholly owned subsidiary in the GlaxoSmithKline (“GSK”) group of companies.

HOME - APVC

APVC is a leading medical technology venture capital firm founded by GlaxoSmithKline in 2013. We invest around the world and take a hands-on role on the boards of start-ups advancing bioelectronic medicines and their enabling technologies. We believe in the fundamental advantage of a diverse workplace and are committed to

creating a fairer

TEAM - APVC - HOME - APVC Juan-Pablo Mas. Juan-Pablo is a partner at APVC in Palo Alto, CA. He represents APVC on the Boards of Cala Health, CVRx, Exo Imaging, Neuspera Medical, Presidio Medical, Saluda Medical, and SetPoint Medical. He was previously an investor at Lightstone Ventures and Morgenthaler Ventures. He previously served as a Board observer at

Ardian

UPDATES - APVC

27 January 2021. SetPoint Medical Raises $64M in Preferred Stock Financing to Support Pivotal Trial for its Novel Bioelectronic Platform. Portfolio News. read more. News & Comments. 26 January 2021. We are proud to announce that APVC Executive-in-Residence, Rami Elghandour was recently appointed Chairman of the Board and CEO of

Arcellx.

PORTFOLIO - APVC - HOME - APVC Saluda Medical. Saluda Medical is dedicated to improving patients’ lives by providing personalized and responsive neuromodulation therapy. The company has developed Evoke®, the first and only Closed-Loop Spinal Cord Stimulation (SCS) System designed to optimize pain relief by measuring and recording each patient’s unique response to stimulation, and then making millions of real-time

PRIVACY NOTICE

Your trust is important to us. We are Action Potential Venture Capital Limited (“APVC”), a wholly owned subsidiary in the GlaxoSmithKline (“GSK”) group of companies.

COOKIE POLICY

This website and the contact information contained therein is not intended for reporting adverse events. If you have a question about a GSK product or want to report a side effect, please call the GSK Response Center at 1-888-825-5249.

HOME - APVC

APVC is a leading medical technology venture capital firm founded by GlaxoSmithKline in 2013. We invest around the world and take a hands-on role on the boards of start-ups advancing bioelectronic medicines and their enabling technologies. We believe in the fundamental advantage of a diverse workplace and are committed to

creating a fairer

TEAM - APVC - HOME - APVC Juan-Pablo Mas. Juan-Pablo is a partner at APVC in Palo Alto, CA. He represents APVC on the Boards of Cala Health, CVRx, Exo Imaging, Neuspera Medical, Presidio Medical, Saluda Medical, and SetPoint Medical. He was previously an investor at Lightstone Ventures and Morgenthaler Ventures. He previously served as a Board observer at

Ardian

UPDATES - APVC

27 January 2021. SetPoint Medical Raises $64M in Preferred Stock Financing to Support Pivotal Trial for its Novel Bioelectronic Platform. Portfolio News. read more. News & Comments. 26 January 2021. We are proud to announce that APVC Executive-in-Residence, Rami Elghandour was recently appointed Chairman of the Board and CEO of

Arcellx.

PORTFOLIO - APVC - HOME - APVC Saluda Medical. Saluda Medical is dedicated to improving patients’ lives by providing personalized and responsive neuromodulation therapy. The company has developed Evoke®, the first and only Closed-Loop Spinal Cord Stimulation (SCS) System designed to optimize pain relief by measuring and recording each patient’s unique response to stimulation, and then making millions of real-time

PRIVACY NOTICE

Your trust is important to us. We are Action Potential Venture Capital Limited (“APVC”), a wholly owned subsidiary in the GlaxoSmithKline (“GSK”) group of companies.

COOKIE POLICY

This website and the contact information contained therein is not intended for reporting adverse events. If you have a question about a GSK product or want to report a side effect, please call the GSK Response Center at 1-888-825-5249.

HOME - APVC

APVC is a leading medical technology venture capital firm founded by GlaxoSmithKline in 2013. We invest around the world and take a hands-on role on the boards of start-ups advancing bioelectronic medicines and their enabling technologies. We believe in the fundamental advantage of a diverse workplace and are committed to

creating a fairer

TEAM - APVC - HOME - APVC Juan-Pablo Mas. Juan-Pablo is a partner at APVC in Palo Alto, CA. He represents APVC on the Boards of Cala Health, CVRx, Exo Imaging, Neuspera Medical, Presidio Medical, Saluda Medical, and SetPoint Medical. He was previously an investor at Lightstone Ventures and Morgenthaler Ventures. He previously served as a Board observer at

Ardian

UPDATES - APVC

27 January 2021. SetPoint Medical Raises $64M in Preferred Stock Financing to Support Pivotal Trial for its Novel Bioelectronic Platform. Portfolio News. read more. News & Comments. 26 January 2021. We are proud to announce that APVC Executive-in-Residence, Rami Elghandour was recently appointed Chairman of the Board and CEO of

Arcellx.

PORTFOLIO - APVC - HOME - APVC Saluda Medical. Saluda Medical is dedicated to improving patients’ lives by providing personalized and responsive neuromodulation therapy. The company has developed Evoke®, the first and only Closed-Loop Spinal Cord Stimulation (SCS) System designed to optimize pain relief by measuring and recording each patient’s unique response to stimulation, and then making millions of real-time

menu

* Home

* About

* People

* Portfolio

* News

* Contact

CHARGING INNOVATION TO DELIVER MEDICINES… We support innovators and entrepreneurs that are pioneering the journey to a bioelectronic future. THAT SPEAK THE ELECTRICAL LANGUAGE OF THE BODY

ABOUT

PORTFOLIO

NEWS

* @2017 Action Potential Venture Capital Ltd. All rights reserved.

* Home

* Legal Statement

* Privacy Statement